机构：[1]Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China[2]Department of Gynecology, Qilu Hospital of Shandong University, Jinan, China[3]Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China[4]Department of Gynecological Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China中山大学附属第二医院[5]Department of Gynecologic Oncology, Women's Hospital, Zhejiang University School of Medicine, Hangzhou, China浙江大学医学院附属妇产科医院[6]Department of Obstetrics and Gynecology, The Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China[7]Department of Obstetrics and Gynecology, The Second Hospital of Jilin University, Changchun, China[8]Department of Gynecologic Oncology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China[9]Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China华中科技大学同济医学院附属同济医院[10]Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[11]Department of Obstetrics and Gynecology, International Peace Maternity and Child Health Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China[12]Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China[13]Department of Obstetrics and Gynecology, West China Second Hospital, Sichuan University, Chengdu, China[14]Department of Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China[15]Department of Gynecologic Oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, Chongqing, China
The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 has rapidly spread globally. Cancer patients are at a higher risk of being infected with the coronavirus and are more likely to develop severe complications, as compared to the general population. The increasing spread of COVID-19 presents challenges for the clinical care of patients with gynecological malignancies. Concerted efforts should be put into managing gynecological malignancies in an orderly manner by strictly implementing the measures that are specifically developed for controlling the spread of COVID-19. We have drafted Recommendations on Management of Gynecological Malignancies during the COVID-19 Pandemic based on our experience on controlling COVID-19 pandemic in China. We recommend that patients with gynecological malignancies should be managed in hierarchical and individualized manners in combination with local conditions related to COVID-19. Medical care decision should be balanced between controlling COVID-19 pandemic spread and timely diagnosis and treatment for gynecologic oncology patients.
第一作者机构：[1]Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China
通讯作者：
通讯机构：[1]Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China[*1]Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, No.154, Anshan Road, Heping District, Tianjin 300052, China.
推荐引用方式(GB/T 7714)：
Yingmei Wang ,Shiqian Zhang ,Lihui Wei ,et al.Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists[J].JOURNAL OF GYNECOLOGIC ONCOLOGY.2020,31(4):doi:10.3802/jgo.2020.31.e68.
APA：
Yingmei Wang ,,Shiqian Zhang ,,Lihui Wei ,,Zhongqiu Lin ,,Xinyu Wang ,...&Fengxia Xue.(2020).Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.JOURNAL OF GYNECOLOGIC ONCOLOGY,31,(4)
MLA：
Yingmei Wang ,,et al."Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists".JOURNAL OF GYNECOLOGIC ONCOLOGY 31..4(2020)
